Login / Signup
Derek J Jonker
(Derek Jonker)
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 7
Top Topics
Phase Iii
Clinical Trial
Weight Loss
Metastatic Colorectal Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Joao Paulo Solar Vasconcelos
,
Nan Chen
,
Emma Titmuss
,
Dongsheng Tu
,
Stephanie Y Brule
,
Rachel Goodwin
,
Derek J Jonker
,
Timothy Jay Price
,
Zalcberg John
,
Malcolm J Moore
,
Christos S Karapetis
,
Lillian L Siu
,
Jeremy Shapiro
,
R John Simes
,
Sharlene Gill
,
Chris J O'Callaghan
,
Jonathan M Loree
Transverse colon primary tumor location as a biomarker in metastatic colorectal cancer: A pooled analysis of CCTG/AGITG CO.17 and CO.20 randomized clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Jonathan M Loree
,
Emma Titmuss
,
James T Topham
,
Hagen F Kennecke
,
Harriet E Feilotter
,
Shakeel Virk
,
Young S Lee
,
Kimberly C Banks
,
Katie Quinn
,
Aly Karsan
,
Daniel J Renouf
,
Derek J Jonker
,
Dongsheng Tu
,
Chris J O'Callaghan
,
Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (15) (2024)
Jonathan M Loree
,
Emma Titmuss
,
James T Topham
,
Hagen F Kennecke
,
Harriet E Feilotter
,
Shakeel Virk
,
Young S Lee
,
Kimberly C Banks
,
Katie Quinn
,
Aly Karsan
,
Daniel J Renouf
,
Derek J Jonker
,
Dongsheng Tu
,
Chris J O'Callaghan
,
Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (15) (2024)
Jonathan M Loree
,
Emma Titmuss
,
James T Topham
,
Hagen F Kennecke
,
Harriet E Feilotter
,
Shakeel Virk
,
Young S Lee
,
Kimberly C Banks
,
Katie Quinn
,
Aly Karsan
,
Daniel J Renouf
,
Derek J Jonker
,
Dongsheng Tu
,
Chris J O'Callaghan
,
Eric X Chen
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Joao Paulo Solar Vasconcelos
,
Nan Chen
,
Emma Titmuss
,
Dongsheng Tu
,
Stephanie Y Brule
,
Rachel Goodwin
,
Derek J Jonker
,
Timothy Jay Price
,
Zalcberg John
,
Malcolm J Moore
,
Christos S Karapetis
,
Lillian L Siu
,
Jeremy Shapiro
,
R John Simes
,
Sharlene Gill
,
Chris J O'Callaghan
,
Jonathan M Loree
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (6) (2024)
Jonathan M Loree
,
Emma Titmuss
,
James T Topham
,
Hagen F Kennecke
,
Harriet E Feilotter
,
Shakeel Virk
,
Young S Lee
,
Kimberly C Banks
,
Katie Quinn
,
Aly Karsan
,
Daniel J Renouf
,
Derek J Jonker
,
Dongsheng Tu
,
Chris J O'Callaghan
,
Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (15) (2024)
Josep Tabernero
,
Takayuki Yoshino
,
Sebastian Stinzing
,
Aimery deGramont
,
Peter Gibbs
,
Derek J Jonker
,
Peter Nygren
,
Christos A Papadimitriou
,
Gerald W Prager
,
Roger Tell
,
Heinz-Josef Lenz
A Randomized Phase III Study of Arfolitixorin Versus Leucovorin with 5-Fluorouracil, Oxaliplatin and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.
Cancer research communications
(2023)